Raymond James Financial’s LeMaitre Vascular LMAT Stock Holding History

Raymond James Financial’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.59M	Sell	27,039 -895	-3%	-$91.8K	﹤0.01%	3299
2026 Q1	$3.05M	Sell	27,934 -542	-2%	-$51.7K	﹤0.01%	3006
2025 Q4	$2.31M	Buy	28,476 +1,164	+4%	+$100K	﹤0.01%	3156
2025 Q3	$2.39M	Buy	27,312 +521	+2%	+$46.5K	﹤0.01%	3035
2025 Q2	$2.22M	Sell	26,791 -47,045	-64%	-$3.93M	﹤0.01%	2994
2025 Q1	$6.19M	Sell	73,836 -87,872	-54%	-$8.17M	﹤0.01%	2187
2024 Q4	$14.9M	Buy	+161,708	New	+$15.6M	0.01%	1523

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Raymond James Financial's LMAT Position: Q2 2026 in Review

Raymond James Financial reduced its LeMaitre Vascular (LMAT) stake by 3.2% in Q2 2026, selling an estimated $91.8K and leaving 27,039 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #3299.

Raymond James Financial first reported a position in LMAT in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.9M in Q4 2024. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Raymond James Financial held 27,039 shares of LeMaitre Vascular worth $2.59M as of Q2 2026.
Raymond James Financial sold 895 LeMaitre Vascular shares in Q2 2026, an estimated $91.8K.
LeMaitre Vascular made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3299 holding.
Raymond James Financial first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 7 quarters since.
Raymond James Financial's LeMaitre Vascular position peaked at $14.9M in Q4 2024.
327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.